SI
SI
discoversearch

Biotech / Medical
Neptune Technologies & Bioressources Inc. - NTB.V
An SI Board Since July 2011
Posts SubjectMarks Bans Symbol
252 13 0 NEPT
Emcee:  Sultan Type:  Unmoderated
Neptune Technologies & Bioressources Inc. researches, develops and commercializes proprietary bioactive
ingredients and products with the goal of superior added-value and clinically proven health benefits. The
Company extracts a range of bioactive ingredients such as novel proprietary omega-3 phospholipids from
abundant yet underexploited marine biomass including Krill, a cold deep water zooplankton. Neptune’s
first commercially available product is Neptune Krill Oil (NKO®), which represents marine based omega-3
phospholipids with potential in cardiovascular, cognitive and anti-inflammatory disorders. Neptune is pursuing
market opportunities in the nutraceutical market including dietary supplements and functional foods. The
Company is also pursuing opportunities in the pharmaceutical market through its pharmaceutical subsidiaries,Acasti and NeuroBioPharm (including medical food, over-the-counter and prescription drug applications).

neptunebiotech.com

NOTE: Neptune trades on Toronto.. For Canadian quote, enter NTB.TO

Acasti Pharma Inc. is 58% owned by Neptune.. For Canadian quote, go to APO.V

acastipharma.com
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
252Neptune's Production Ramp-Up on Target Reaches Annualized ProducSultan-August 14
251Quite a miss and a dump in ENZY.. Don't have a position there but no questiSultan-August 5
250ENZY down 35% off poor earnings and guidance. Could be NEPT has been falling inThe Ox-August 5
249No ideas Ox.. No news release although they should give an update on plant raSultan1August 4
248Any thoughts on the downtrend, now that it's below $2/share?The Ox-August 4
247Neptune First Qtr. Results finance.yahoo.com Acasti First Qtr. Results finaSultan-July 15
246Acasti Completes Phase II Double Blind (TRIFECTA) and Pharmacokinetic Trials fiSultan1July 9
245AGM Presentationneptunebiotech.comSultan1June 20
244This was expected.. Harlands were the founders so some of them were entrenched Sultan-June 16
243Only surprise is how long it took. He is the former ceo's son :)rkrw1June 16
242 Acasti Announces Resignation of Chief Financial Officer [graphic]LAVAL, QuebecThe Ox-June 16
241 NEPTUNE STRENGTHENS POSITION IN KRILL OIL MARKET: Opens New Plant, Expands OMSultan1June 16
240Neptune Sherbrooke Plant to Resume Production Product Line ExpandeSultan1June 13
239Sour grapes, most likely. Hard to see how he intends to keep a seat on the boarThe Ox-May 30
238I was expecting this but the scale of claims are ridiculous.. Neptune TechnoloSultan-May 30
237Neptune Announces Fourth Quarter and Fiscal Year Results finance.yahoo.com AcaSultan1May 21
236Neptune Announces Proposed Director Nominees for Its Upcoming Annual General MeeSultan1May 16
235Photo Release -- Neptune Provides Update on Plant Operating Permits LAVAL, QuebSultan1May 8
234Neptune Receives CSST Report LAVAL, Quebec, May 8, 2014 (GLOBE NEWSWIRE) -- NepSultan-May 8
233Acasti Presents at National Lipid Association Scientific Sessions (May 1-4, 2014Sultan1May 5
232Acasti to Present at Two Scientific Forums Laval, Québec, CANADA – May 1, Sultan-May 1
231I think the factory blowup and subsequent disruption to their business momentum Sultan1April 28
230This is probably excellent news, although I can't say I know enough about thThe Ox-April 28
229Here we go.. May be we now get a CEO who can move the company to next level.. WiSultan-April 28
228Neptune and Enzymotec Conclude Final Patent Infringement Settlement and License Sultan2April 27
227Neptune Obtains New US Patent Relating to Treatment of Alzheimer's finance.Sultan2April 24
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
Copyright © 1995-2014 Knight Sac Media. All rights reserved.Stock quotes are delayed at least 15 minutes - See Terms of Use.